scholarly journals Defense Mechanisms in Patients with Irritable Bowel Syndrome and Their Relationship with Symptom Severity and Quality of Life

2019 ◽  
Vol 11 (3) ◽  
pp. 158-165
Author(s):  
Fahimeh Saeed ◽  
Mansour Salehi ◽  
Kaveh Alavi ◽  
Hossein Ajdarkosh ◽  
Fatemeh Kashaninasab ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Irritable Bowel Syndrome ◽  
Defense Mechanisms ◽  
Control Group ◽  
Life Questionnaire ◽  
Acting Out ◽  
The Mean ◽  
Irritable Bowel ◽  
Passive Aggression

BACKGROUND Despite the fact that there is theoretical evidence about the association between unconscious defense mechanisms and irritable bowel syndrome (IBS), experimental evidence in this regard is limited. The aim of the present study was to compare the defense mechanisms used by the patients with IBS and a control group, and to investigate the relationship between these mechanisms with the severity of the disease and patients’ quality of life. METHODS Fourty-five patients with IBS (mean age of 37.1 years; 14 males) and 45 controls (mean age of 38.0 years; 13 males) were evaluated. IBS diagnosis was determined based on Rome III criteria and the predominant pattern of the disease was determined based on the patient’s history (13 diarrheapredominant, 16 constipation-predominant, and 16 alternating IBS). Defense Style Questionnaire-40, IBS Severity Scale, and IBS-Quality of Life questionnaire were used. RESULTS The mean scores of projection, acting-out, somatization, autistic fantasy, passive-aggression, and reaction formation in the IBS group were significantly higher than the control group and the mean scores of humor and anticipation mechanisms were higher in the control group. There was no significant correlation between the score of defense mechanisms and the severity of IBS and the patients’ quality of life. CONCLUSION The severity of immature defenses in the IBS group was significantly higher, whereas the severity of mature defenses was higher in the control group. These defenses were not correlated with the severity of IBS. Considering the limited sample size, these relationships need to be more investigated.

scholarly journals Evaluation of the Impact of Self-Efficacy-Based Training on Depression, Self-Care Behaviors, and Quality of Life in Patients with Irritable Bowel Syndrome

2020 ◽  
pp. 90-95
Keyword(s):  
Quality Of Life ◽  
Irritable Bowel Syndrome ◽  
Self Efficacy ◽  
Self Care ◽  
Control Group ◽  
Life Questionnaire ◽  
Irritable Bowel ◽  
The Impact

Background and Objectives: Irritable bowel syndrome is the most common diagnosis among patients with gastrointestinal diseases and can adversely affect their quality of life. In this regard, the present study aimed to evaluate the effectiveness of self-efficacy-based training on depression, self-care behaviors, and the quality of life of patients with irritable bowel syndrome. Materials and Methods: This applied quasi-intervention study was conducted based on a pretest-posttest design with a control group and follow-up. The statistical population included all patients with irritable bowel syndrome who referred to Khorshid Hospital in Isfahan, Iran from September to November 2019. The samples were selected using the convenience sampling method. In total, 30 patients with irritable bowel syndrome were included in the study and randomly divided into two groups of intervention and control. The data were collected using Beck depression inventory, self-care questionnaire, and quality of life questionnaire. The intervention group received four sessions of self-efficacy training (one session per week for 90 min), while the control group did not receive any training. Two months later, the follow-up period was completed. The collected data were analyzed using repeated measures of analysis of variance in SPSS software (version 22). Results: The results showed that self-efficacy training was effective in decreasing depression (P<0.0001, F=35.39) and increasing quality of life (P<0.0001, F=120.30) and self-care behaviors (P<0.0001, F=70.50) in patients with irritable bowel syndrome. Conclusion: It can be concluded that training based on self-efficacy theory can effectively reduce depression and increase self-care behaviors and quality of life in patients with irritable bowel syndrome.

scholarly journals Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
L. Quénéhervé ◽  
D. Drui ◽  
J. Blin ◽  
M. Péré ◽  
E. Coron ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Irritable Bowel Syndrome ◽  
Adrenal Insufficiency ◽  
Gastrointestinal Symptoms ◽  
Control Group ◽  
Non Profit ◽  
Acute Adrenal Insufficiency ◽  
Irritable Bowel ◽  
Rome Iv

AbstractGastrointestinal symptoms are frequent in acute adrenal insufficiency. Although digestive symptoms can significantly reduce quality of life, they are rarely described in patients with treated chronic adrenal insufficiency (CAI). We aimed to characterize digestive symptoms in CAI patients. We used the section pertaining functional bowel disorders of the Rome IV questionnaire. A questionnaire was published on the website of the non-profit patient association “Adrenals” (NPPA of CAI patients) for five months. Information on demographics, characteristics of adrenal insufficiency, digestive symptoms and quality of life was collected. The relatives of CAI patients served as a control group. We analyzed responses of 33 control subjects and 119 patients (68 primary adrenal insufficiency (PAI), 30 secondary adrenal insufficiency (SAI) and 21 congenital adrenal hyperplasia (CAH)). Abdominal pain at least once a week over the past 3 months was reported by 40%, 47% and 33% of patients with PAI, SAI and CAH respectively versus 15% for the controls (p = 0.01). Symptoms were consistent with the Rome IV criteria for irritable bowel syndrome in 27%, 33% and 33% of patients respectively versus 6% for the controls (p < 0.0001). Quality of life was described as poor or very poor in 35%, 57% and 24% of patients respectively versus 5% for the controls (p < 0.0001). In conclusion, digestive symptoms are frequent and incapacitating in CAI patients and similar to symptoms of irritable bowel syndrome in 30% of CAI patients. Assessment and management of digestive symptoms should be considered a priority for physicians treating patients with CAI.

scholarly journals Effect of Multispecies Probiotic Supplementation on Irritable Bowel Syndrome

2019 ◽  
pp. 1-9
Author(s):  
Saeed Yazdani Ashtiani ◽  
Mersad Amery
Keyword(s):  
Quality Of Life ◽  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Therapeutic Option ◽  
Intervention Group ◽  
Control Group ◽  
Controlled Clinical Trial ◽  
Probiotic Supplementation ◽  
Irritable Bowel

Background: Irritable bowel syndrome (IBS) is a common, chronic and sometimes disabling functional disorder of the gastrointestinal system and its treatment remains as health problem. Thus the aim of this study was to evaluate the Effect of multispecies probiotic supplementation, as a novel and Controversial therapeutic method on Irritable bowel syndrome. Materials and Methods: In this randomized double blind Placebo-controlled clinical trial, 60 patients with IBS were enrolled. The patients were divided randomly into two groups. Patients in intervention group received two 500 mg probiotic capsules (Familact®) and in control group, received two 500 mg placebo capsules daily for 30 consecutive days. The symptoms and quality of life were measured and compared at the beginning and just after the end of study for each case. Results: Results showed the mean score of Abdominal pain after 1 month of treatment in the probiotic group was significantly lower than the control group (1.76 ± 2.04 vs. 2.88 ± 2.25, P=0.049, respectively). While, other symptoms and quality of life did not change significantly (P>0.05). Furthermore, defecation habit and global symptoms improvement was similar after intervention in both groups and we did not observe significant differences in these items (P>0.05). Conclusion: The results of this study showed the beneficial effects of multispecies probiotic supplementation in controlling IBS patients’ abdominal pain. thus it can be prescribed as a therapeutic option in addition to standard therapy and significantly lead to better control of this symptom in the short term.

scholarly journals Comparison of Mindfulness-Based Cognitive Therapy and Neurofeedback on Quality of Life of Patients With Irritable Bowel Syndrome

2021 ◽  
Vol 6 (4) ◽  
pp. 129-136
Author(s):  
Noura Khosh Chin Gol ◽  
◽  
Bahman Akbari ◽  
Leila Moghtader ◽  
Iraj Shakerinia ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Irritable Bowel Syndrome ◽  
Cognitive Therapy ◽  
General Health ◽  
Control Group ◽  
Total Quality ◽  
Post Test ◽  
Irritable Bowel

Background: Irritable Bowel Syndrome (IBS) is one of the most common gastrointestinal disorders and is usually associated with abdominal pain. This study aimed to compare the effectiveness of mindfulness and neurofeedback on quality of life in patients with irritable bowel syndrome. Materials & Methods: The present study was a pretest-posttest control group design with a two-month follow-up. The study population included all women with irritable bowel syndrome referred to gastroenterology centers and clinics of Qazvin city in 2019. Patients were selected by convenience sampling and randomly assigned into two experimental and one control groups (n=45). The experimental groups underwent Mindfulness-Based Cognitive Therapy (MBCT) and Neurofeedback (NFB). The Rome-III diagnostic criteria form and the WHOQOLBREF were administered. Data were analyzed using repeated measure analysis of variance. Results: There was significant difference between NFB and control group for total quality of life and all its components. The mean between-group difference (MD) of total quality of life score in NFB compared to control group was 21.2±2.58 in post-test and 15.4±2.35 in follow-up (P<0.05). MBCT group was significantly different with the control group in component of general health both in post-test (MD= 0.93±0.53) and follow-up (MD=0.73±0.53), (P<0.05). Conclusion: NFB therapy considerably improved the quality of life of patients with IBS that was remained after two months of follow-up, while MBCT was only effective on improvement of general health in comparison with the control group.

scholarly journals Tratamiento del síndrome de intestino irritable por gastroenterólogos: resultados de un estudio de corte transversal a partir de una encuesta elaborada por expertos

2021 ◽  
Vol 51 (3) ◽  
Author(s):  
Luis Soifer ◽  
José Tawil ◽  
Alejandro Rey ◽  
Laura Solé ◽  
Silvia Bernstein
Keyword(s):  
Quality Of Life ◽  
Irritable Bowel Syndrome ◽  
Polyethylene Glycol ◽  
Symptomatic Relief ◽  
Colonic Transit ◽  
Significant Deterioration ◽  
Medical Associations ◽  
The Mean ◽  
Irritable Bowel

Introduction. Irritable bowel syndrome (IBS) accounts for a significant deterioration in the quality of life of patients who suffer from it and is a common reason for consultation in gastroenterology. The treatment of this syndrome includes a wide variety of medications and recommendations based on different factors of its physiopathology. However, the results are usually variable and sometimes unsatisfactory for either the patient or the treating physician. The main objective of the present work is to describe the different treatments used by gastroenterologists in the management of IBS in Argentina. Materials and methods. Questionnaire of forty-seven questions, prepared by experts, distributed by medical associations of gastroenterology in Argentina and answered by specialists via Google Forms. Results. 304 responses, 157 from women (51.6%) and 147 from men (48.4%). The mean age was 44 and 49.9 years, respectively. 87.5% consider improvement of quality of life as the main goal of treatment. Regarding physiopathology of diarrhea variant irritable bowel syndrome (IBS-D), 49.5% considered emotional stress, while for constipation variant irritable bowel syndrome (IBS-C), 42.8% considered it multifactorial, with a predominance of slow colonic transit. No treatment option was rated as very effective by more than 50% of the respondents. Rifaximin was considered the most effective treatment in IBS-D, while polyethylene glycol was for IBS-C. Statistical significant differences were observed among gastroenterology subspecialties in the treatment of IBS-D with respect to the efficacy of diet, amitriptyline and antibiotics other than rifaximin, and regarding the effectiveness for bisacodyl/picosulfate and antibiotics in the treatment of IBS-C. Conclusion. The most common pathophysiological mechanismin IBS-D is stress. The vast majority of respondents consider that the main goal of treatment is the improvement of the quality of life, over symptomatic relief. None of the drugs is considered very effective in the treatment of the different IBS variants by at least 50% of those surveyed. Statistically significant differences were observed in the proportion of monthly consultations for IBS regarding to age and in the effectiveness considered for some treatments in relation to the subspecialty of physicians. The therapeutic approach to IBS by Argentine gastroenterologists is varied and somewhat heterogeneous, resulting in a still inappropriate management of this condition.

Irritable Bowel Syndrome–Quality of Life Questionnaire--Chinese Translation

2007 ◽  
Author(s):  
Wen-wei Huang ◽  
Fu-sheng Zhou ◽  
Donald M. Bushnell ◽  
Chiaka Diakite ◽  
Xiao-huan Yang
Keyword(s):  
Quality Of Life ◽  
Irritable Bowel Syndrome ◽  
Life Questionnaire ◽  
Chinese Translation ◽  
Quality Of Life Questionnaire ◽  
Irritable Bowel

Specific quality of life questionnaire in irritable bowel syndrome. Effect of fedotozine

1995 ◽  
Vol 108 (4) ◽  
pp. A581 ◽  
Author(s):  
O. Chassany ◽  
J. Genève ◽  
J.L. Abitbol ◽  
B. Scherrer ◽  
M. Dapoigny ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Irritable Bowel Syndrome ◽  
Life Questionnaire ◽  
Quality Of Life Questionnaire ◽  
Irritable Bowel

scholarly journals Validation of a specific quality of life questionnaire for functional digestive disorders

Gut ◽  
1999 ◽  
Vol 44 (4) ◽  
pp. 527-533 ◽  
Author(s):  
O Chassany ◽  
P Marquis ◽  
B Scherrer ◽  
N W Read ◽  
T Finger ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Irritable Bowel Syndrome ◽  
Psychometric Validation ◽  
Life Questionnaire ◽  
Quality Of Life Questionnaire ◽  
Sf 36 ◽  
Digestive Disorders ◽  
Functional Digestive Disorders ◽  
Irritable Bowel

BACKGROUNDDyspepsia and irritable bowel syndrome are suitable conditions for assessment of quality of life. Their similarities justify the elaboration of a single specific questionnaire for the two conditions.AIMSTo examine the process leading to the validation of the psychometric properties of the functional digestive disorders quality of life questionnaire (FDDQL).METHODSInitially, the questionnaire was given to 154 patients, to assess its acceptability and reproducibility, analyse its content, and reduce the number of items. Its responsiveness was tested during two therapeutic trials which included 428 patients. The questionnaire has been translated into French, English, and German. The psychometric validation study was conducted in France, United Kingdom, and Germany by 187 practitioners. A total of 401 patients with dyspepsia or irritable bowel syndrome, defined by the Rome criteria, filled in the FDDQL and generic SF-36 questionnaires.RESULTSThe structure of the FDDQL scales was checked by factorial analysis. Its reliability was expressed by a Cronbach’s α coefficient of 0.94. Assessment of its discriminant validity showed that the more severe the functional digestive disorders, the more impaired the quality of life (p<0.05). Concurrent validity was supported by the correlation found between the FDDQL and SF-36 questionnaire scales. The final version of the questionnaire contains 43 items belonging to eight domains.CONCLUSIONSThe properties of the FDDQL questionnaire, available in French, English, and German, make it appropriate for use in clinical trials designed to evaluate its responsiveness to treatment among patients with dyspepsia and irritable bowel syndrome.

Sign in / Sign up

Export Citation Format

Share Document